Skip to main content

Cue Biopharma Inc. Common Stock (CUE)

About The Company

CUE Stock Market Logo

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401.

IPO Year Sector Industry
2018 Health Care Biotechnology: Pharmaceutical Preparations

Cue Biopharma Inc. (CUE) Latest News

Company Contact & Address (CUE)

Corporate Headquarters Phone Website
United States
+1 617 949-2680 Official CUE Website

CUE Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ CUE

Jobs & Employment at Cue Biopharma Inc.

LinkedIn Company Page
Official Career & Employment Page Careers & Jobs at Cue Biopharma Inc. (CUE)

Related & Similar Stock Symbols

PFC Stock Market Price & News


Premier Financial Corp. Common Stock

SXI Stock Market Price & News


Standex International Corporation Common Stock

COF^I Stock Market Price & News


Capital One Financial Corporation Depositary shares each …